AVGO vs RCAT Stock Comparison
AVGO currently leads RCAT in this stock comparison, with AIQ scores of 52 vs 34. The clearest difference is quality, while RCAT has the stronger value profile.
What is the main difference between AVGO and RCAT?
AVGO leads the current stock comparison as Broadcom Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Broadcom Inc. vs Red Cat Holdings, Inc.
AVGO leads
AVGO leads by 18 AIQ points, primarily on Quality and Momentum, but the lead has narrowed from 31 points over 30 sessions. Wall Street currently favors RCAT on target upside.
Fragile: 3 of 6 evidence groups support AVGO, its lead is narrowing, and its current signal state is conflicted.
Broadcom Inc.
Red Cat Holdings, Inc.
The Algovestiq AIQ Score currently favors AVGO over RCAT, 52 versus 34 as of Oct 31, 2026. AVGO's advantage is driven primarily by stronger quality and momentum, while RCAT holds the stronger value profile. AVGO also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors RCAT. 3 of 6 covered evidence groups favor AVGO today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. AVGO lead: Weakening — the AIQ differential moved from 31 to 18 points over 30 sessions.
Compare Broadcom Inc. and Red Cat Holdings, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AVGO and RCAT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality85 vs 33AVGO +52
- Momentum40 vs 26AVGO +14
- Value30 vs 34RCAT +4
- Risk Resilience51 vs 52Even
3 of 6 evidence groups favor AVGO. AVGO’s edge is concentrated in quality and momentum; RCAT keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Momentum +16
New signals
- MACD Bullish Crossover — bullish, momentum, short horizon
Largest factor move: Momentum +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 5 active signals are unchanged.
AVGO's lead widened by 4 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — AVGO and RCAT both carry a full feed there.
The central trade-off
AVGO (Broadcom Inc.): the stronger current systematic profile, led by quality and momentum.
RCAT (Red Cat Holdings, Inc.): the counter-case, on value, valuation, analyst expectations — but at materially higher volatility, 64.8% against 43%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AVGOAVGO on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AVGOAVGO on combined revenue and EPS growth.
Value
RCATRCAT on the peer-relative Value factor, by 4 points.
Momentum
AVGOAVGO on the Momentum factor, by 14 points.
Lower downside
AVGOAVGO carries the lower 1-month annualized volatility.
Analyst upside
RCATRCAT on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors AVGO, analyst targets favor RCAT. That disagreement is the most useful thing on this page.
| Measure | AVGO | RCAT | Note |
|---|---|---|---|
| Implied upside to target | +55.3% | +217.7% | RCAT has more room |
| Target dispersion | +49.4% | +129.2% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 19 | 6 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor AVGO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | AVGO | 52 vs 34 |
| Fundamentals | AVGOon balance | revenue growth 14.9% vs 30.5%; EPS growth 26.5% vs -18.2%; TTM ROE 36.4% vs -35%; gross margin 67% vs 8.6%; operating margin 43.7% vs -161.1% — AVGO takes 4 of 5 decided legs, not all of them |
| Valuation | RCAT | Value 30 vs 34 |
| Technicals | AVGO | Price vs 50-day -7.9% vs -32.6%; vs 200-day -4.3% vs -53.6% |
| Risk Resilience | Even | Risk Resilience 51 vs 52 |
| Analyst expectations | RCAT | Target upside 55.3% vs 217.7% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and RCAT and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is wide at 18 points. (supports the conclusion holding)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AVGO.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28AVGO lead: Weakening — the AIQ differential moved from 31 to 18 points over 30 sessions.
- Today
- AVGO +18
- 52 vs 34
- 7 sessions ago
- AVGO +12
- 46 vs 34
- 30 sessions ago
- AVGO +31
- 65 vs 34
- 90 sessions ago
- AVGO +5
- 43 vs 38
The lead changed hands once in this window, most recently on Aug 19 when RCAT moved ahead of AVGO.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish, conflicted
No signal that the other name lacks.
1 bullish / 2 bearish / 2 neutral, conflicted
Only RCAT
- Bollinger Band Squeeze — neutral, volatility, short horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (7.36%)
Both carry 3 more signals that do not separate them: Death Cross Active, Downtrend Structure Active, MACD Bullish Crossover.
AVGO leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 4 points over the same session — price and model disagree (price -5.48%, AIQ +4 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -8.32%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1RCAT closes the Quality gap — currently 52 points behind, the largest single contributor to AVGO's edge.
- 2RCAT's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3AVGO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
- 4The narrowing continues — the lead has already given back 13 points over 30 sessions, and a further 18-point move would eliminate AVGO's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AVGO leads on balance| Metric | AVGO | RCAT |
|---|---|---|
| Revenue growth (YoY) | 14.9% | 30.5% |
| EPS growth (YoY) | 26.5% | -18.2% |
| Gross margin | 67% | 8.6% |
| Operating margin | 43.7% | -161.1% |
| Return on equity (TTM) | 36.4% | -35% |
| Debt to equity | 0.74 | 0.05 |
Performance
AVGO leads 5 of 6 windows| Metric | AVGO | RCAT |
|---|---|---|
| 1 week (5 sessions) | 4.1% | 7.2% |
| 1 month (20 sessions) | 0.2% | -24% |
| 3 months (63 sessions) | -9.3% | -33.5% |
| 6 months (126 sessions) | -13.2% | -55.6% |
| Year to date | 1.6% | -38.1% |
| 1 year (252 sessions) | -0.7% | -56% |
Technicals
AVGO has the stronger structure| Metric | AVGO | RCAT |
|---|---|---|
| RSI (14) | 45.6 | 30.8 |
| ADX (14) | 24.1 | 52.4 |
| Price vs 50-day | -7.9% | -32.6% |
| Price vs 200-day | -4.3% | -53.6% |
| Volatility (1M, annualized) | 43% | 64.8% |
Risk
Split| Metric | AVGO | RCAT |
|---|---|---|
| Beta | 2.18 | 3.6 |
| Sharpe ratio | 0.02 | -0.29 |
| Sortino ratio | 0.03 | -0.57 |
| Max drawdown | -33.2% | -74.8% |
| Current drawdown | -26.9% | -71.7% |
| Annualized volatility | 46% | 105.6% |
| Value at risk (95%) | -4.4% | -9.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVGO or RCAT?
On the Algovestiq AIQ Score, AVGO is the stronger of the two as of Oct 31, 2026, scoring 52 against RCAT's 34. The edge comes from quality and momentum. RCAT is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVGO or RCAT the better buy right now?
AVGO carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor AVGO over RCAT?
The composite weights Quality, Value, Momentum and Risk Resilience. AVGO leads Quality by 52 points; AVGO leads Momentum by 14 points; RCAT leads Value by 4 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVGO or RCAT?
Analyst price targets imply +55.3% upside for AVGO and +217.7% for RCAT, so the Street currently favors RCAT. That points the opposite way to the AIQ Score, which favors AVGO. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVGO or RCAT?
RCAT is the better-valued of the two on the peer-relative Value factor. RCAT on the peer-relative Value factor, by 4 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVGO or RCAT?
AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVGO or RCAT?
AVGO on the Momentum factor, by 14 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVGO or RCAT?
AVGO is the more resilient of the two, so the other name carries the higher downside risk. AVGO carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVGO more profitable than RCAT?
AVGO leads on the comparable margin measures — gross margin 67% vs 8.6%; operating margin 43.7% vs -161.1%; ttm roe 36.4% vs -35%.
Is AVGO's lead over RCAT getting stronger or weaker?
AVGO lead: Weakening — the AIQ differential moved from 31 to 18 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has changed hands once in that window, most recently on 2026-08-19, when RCAT moved ahead of AVGO.
What would change the AVGO vs RCAT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RCAT closes the Quality gap — currently 52 points behind, the largest single contributor to AVGO's edge; RCAT's Death Cross Active resolves — a bearish trend rule currently active against it; AVGO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 13 points over 30 sessions, and a further 18-point move would eliminate AVGO's advantage entirely.
What do the current signals say about AVGO and RCAT?
AVGO: 1 bullish / 2 bearish, conflicted. RCAT: 1 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On RCAT it is Death Cross Active (bearish, long horizon).
Compare AVGO and RCAT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.